Literature DB >> 16487741

Geminin is bound to chromatin in G2/M phase to promote proper cytokinesis.

Enkeleda Nakuci1, Mai Xu, Miguel Angel Pujana, Joan Valls, Wael M Elshamy.   

Abstract

Previous studies suggested that geminin plays a vital role in both origin assembly and DNA re-replication during S-phase; however, no data to support a role for geminin in G2/M cells have been described. Here it is shown that in G2/M-phase, geminin participates in the promotion of proper cytokinesis. This claim can be supported through a series of observations. First, geminin in G2/M is loaded onto chromatin after it is tyrosine phosphorylated. It is unlike S-phase geminin that resides in the nuclear soluble fraction, where it is exclusively S/T phosphorylated. Secondly, on chromatin, geminin gets S/T phosphorylated in late G1; this modification causes the release of geminin from the chromatin. Cyclins bind and phosphorylate geminin in a sequential, cell cycle-dependent manner. These modifications correlated well with geminin departure from the chromatin. This suggests that cyclin functions to either release geminin from chromatin or at least keep it at bay until late S-phase. Thirdly, depletion of geminin from a diploid mammary epithelial cell line (HME) causes cells to arrest in late G2/M-phase. Massive serine-10 phosphorylated histone H3 staining and survivin localization to mid-body were observed; this suggests that they could be arrested in either mitosis or at cytokinesis. Finally, while in the absence of geminin, cyclin B1, chk1 and cdc7 are all over expressed. This paper will demonstrate that only cdc7 is important in maintaining the cytokinesis arrest in the absence of geminin. Only double depletion of geminin and cdc7 induce apoptosis. Our results taken together show, for the first time, that phosphorylation-induction activates oscillation of geminin between both nuclear soluble and chromatin compartments. Chromatin-bound geminin species functions to initiate or maintain proper cytokineses. In the absence of geminin, cells arrest in cytokinesis; this defines a novel checkpoint, monitored by cdc7, rather than cyclin B1 or chk1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487741     DOI: 10.1016/j.biocel.2005.12.017

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

1.  Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance.

Authors:  Kohei Shomori; Keisuke Nishihara; Takayuki Tamura; Shigeru Tatebe; Yasushi Horie; Kanae Nosaka; Tomohiro Haruki; Yuki Hamamoto; Tatsushi Shiomi; Motoki Nakabayashi; Hisao Ito
Journal:  Gastric Cancer       Date:  2010-09-05       Impact factor: 7.370

2.  Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.

Authors:  Diane C Adler-Wailes; Joshua A Kramer; Melvin L DePamphilis
Journal:  Stem Cells Dev       Date:  2016-11-07       Impact factor: 3.272

3.  Spotlight on geminin.

Authors:  Melvin L DePamphilis
Journal:  Breast Cancer Res       Date:  2011-06-01       Impact factor: 6.466

4.  Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells.

Authors:  Lauren Gardner; Rohit Malik; Yoshiko Shimizu; Nicole Mullins; Wael M ElShamy
Journal:  Breast Cancer Res       Date:  2011-05-19       Impact factor: 6.466

5.  Geminin overexpression induces mammary tumors via suppressing cytokinesis.

Authors:  Zannel Blanchard; Rohit Malik; Nicole Mullins; Christine Maric; Hugh Luk; David Horio; Brenda Hernandez; Jeffrey Killeen; Wael M Elshamy
Journal:  Oncotarget       Date:  2011-12

6.  Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Authors:  Zannel Blanchard; Nicole Mullins; Pavani Ellipeddi; Janice M Lage; Shawn McKinney; Rana El-Etriby; Xu Zhang; Raphael Isokpehi; Brenda Hernandez; Wael M Elshamy
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

7.  Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers.

Authors:  Suryatheja Ananthula; Abhilasha Sinha; Mohamed El Gassim; Simran Batth; Gailen D Marshall; Lauren H Gardner; Yoshiko Shimizu; Wael M ElShamy
Journal:  Oncotarget       Date:  2016-04-12

8.  Geminin deficiency enhances survival in a murine medulloblastoma model by inducing apoptosis of preneoplastic granule neuron precursors.

Authors:  Savita Sankar; Ethan Patterson; Emily M Lewis; Laura E Waller; Caili Tong; Joshua Dearborn; David Wozniak; Joshua B Rubin; Kristen L Kroll
Journal:  Genes Cancer       Date:  2017-09

Review 9.  Links between DNA Replication, Stem Cells and Cancer.

Authors:  Alex Vassilev; Melvin L DePamphilis
Journal:  Genes (Basel)       Date:  2017-01-25       Impact factor: 4.096

10.  The molecular underpinning of geminin-overexpressing triple-negative breast cancer cells homing specifically to lungs.

Authors:  Eman Sami; Danielle Bogan; Alfredo Molinolo; Jim Koziol; Wael M ElShamy
Journal:  Cancer Gene Ther       Date:  2021-03-15       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.